Posted On: 09/13/2016 9:44:11 AM
Post# of 72447
Ok, so by the numbers you listed from the 10-K that's 12% dilution over 24 months. (124,608,756 - 111,687,129) = 12,921,627 (divided by 111,687,129) = ~12%. Anyone feel free to correct my math if I am incorrect.
That being said, given all the negative things that have occurred to the share price over the last 2 years, for CTIX to continue to complete clinical trials and progress the drugs at only 12% dilution seems like a pretty reasonable accomplishment to me. Am wrong on that? Is 12% dilution a high figure for a startup biotech company with so many mid-stage trials? I would not think so, but I am not as seasoned as others in this arena.
Comments or thoughts?
That being said, given all the negative things that have occurred to the share price over the last 2 years, for CTIX to continue to complete clinical trials and progress the drugs at only 12% dilution seems like a pretty reasonable accomplishment to me. Am wrong on that? Is 12% dilution a high figure for a startup biotech company with so many mid-stage trials? I would not think so, but I am not as seasoned as others in this arena.
Comments or thoughts?
(1)
(0)
